APA (7th ed.) Citation

MA, G., A, G., EE, D., TA, Y., J, R., SA, P., . . . F, M. (2025). Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 31(7), 1268. https://doi.org/10.1158/1078-0432.CCR-24-3468

Chicago Style (17th ed.) Citation

MA, Gouda, et al. "Human Epidermal Growth Factor Receptor 2 Loss Following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 31, no. 7 (2025): 1268. https://doi.org/10.1158/1078-0432.CCR-24-3468.

MLA (9th ed.) Citation

MA, Gouda, et al. "Human Epidermal Growth Factor Receptor 2 Loss Following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 31, no. 7, 2025, p. 1268, https://doi.org/10.1158/1078-0432.CCR-24-3468.